Trial Profile
To assess efficacy and safety of Tofacitinib in patients with rheumatoid arthritis in clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2018
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Abatacept; Adalimumab; Certolizumab pegol; Etanercept; Golimumab; Infliximab
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 13 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism